All sites C00-96,D32-33,D42-43,D45-47,D76 1790 88.2 4.4 3.6 1.2 2.7
Mouth, pharynx C00-14 26 98.5 0.8 0.8 - -
  Lip C00 4 100.0 - - - -
  Tongue C02 6 100.0 - - - -
  Mouth, other C03-06 9 100.0 - - - -
  Salivary glands C07-08 3 86.7 6.7 6.7 - -
  Pharynx C01,C09-14 4 100.0 - - - -
Digestive organs C15-26 336 78.2 7.6 8.3 2.2 3.7
  Oesophagus C15 9 93.3 4.4 - 2.2 -
  Stomach C16 32 95.1 1.2 1.2 1.9 0.6
  Small intestine C17 7 94.6 - 2.7 2.7 -
  Colon C18 115 93.7 0.5 2.4 1.0 2.3
  Rectum, rectosigmoid C19-20 42 98.6 - 0.5 - 0.9
  Anus C21 3 94.1 5.9 - - -
  Liver C22 25 63.8 14.2 15.0 1.6 5.5
  Gallbladder, bile ducts C23-24 23 53.0 17.4 17.4 4.3 7.8
  Pancreas C25 68 45.6 22.5 21.9 3.5 6.4
  Other digestive organs C26 10 46.0 8.0 16.0 14.0 16.0
Respiratory organs C30-39 111 59.7 21.0 10.7 3.6 5.1
  Nose, sinuses C30-31 3 100.0 - - - -
  Larynx, epiglottis C32 1 100.0 - - - -
  Lung, trachea C33-34 105 58.2 22.1 10.9 3.8 5.0
  Mediastinum, pleura C38 1 42.9 - 28.6 - 28.6
Bone C40-41 2 90.9 - 9.1 - -
Melanoma of the skin C43 50 99.6 0.4 - - -
Skin, non-melanoma C44 82 100.0 - - - -
Mesothelioma C45 3 93.8 6.3 - - -
Autonomic nervous system C47 - - - - - -
Soft tissues C48-49 16 100.0 - - - -
Breast C50 542 99.0 0.5 0.1 0.1 0.3
Female genital organs C51-58 202 94.5 1.7 1.6 1.2 1.1
  Cervix uteri C53 20 97.0 1.0 1.0 1.0 -
  Corpus uteri C54 98 98.4 0.4 0.4 0.4 0.4
  Uterus, other C55,C58 2 16.7 8.3 25.0 25.0 25.0
  Ovary C56 56 90.7 3.6 2.5 1.8 1.4
  Other female genital C51-52,C57 26 93.1 2.3 2.3 0.8 1.5
Urinary organs C64-68 80 92.5 2.0 3.5 0.3 1.8
  Kidney C64 48 91.3 2.5 3.3 0.4 2.5
  Bladder and urinary tract2 C65-68 32 94.3 1.3 3.8 - 0.6
Eye C69 1 83.3 16.7 - - -
Brain, central nervous system C70-72,D32-33,D42-43 71 82.9 - 9.2 0.8 7.0
Thyroid gland C73 67 96.7 3.0 - 0.3 -
Other endocrine glands C74-75 2 87.5 - - - 12.5
Illdefined or unknown C76,C80 45 44.9 20.3 14.1 8.4 12.3
Lymphoid and haematopoietic tissue C81-96,D45-47,D76 153 80.8 6.5 2.5 1.0 9.1
  Hodgkin lymphoma C81 6 100.0 - - - -
  Non-Hodgkin lymphoma C82-86,C96,D76 66 99.1 - - 0.3 0.6
  Malignant immunoproliferative diseases C88 1 50.0 - 25.0 - 25.0
  Myeloma and other plasma cell tumors C90 28 66.4 10.7 7.1 2.1 13.6
  Leukaemia C91-95 36 74.0 15.5 3.3 0.6 6.6
  Myelodysplastic syndromes D46 8 41.0 15.4 5.1 5.1 33.3
  Myeloproliferaitive neoplasms D45,D47 8 37.5 2.5 - 2.5 57.5
Not included above
  Carcinoma in situ of the breast D05 56 100.0 - - - -
  Cervix uteri, non-invasive neoplasms 152 100.0 - - - -
  Borderline tumour of the ovary D39 19 95.7 - 1.1 - 3.2
  Basal cell carcinoma of the skin 501 100.0 - - - -
1 The following order of preference for confirmation of the diagnosis is used:
1. Histology (including autopsy, and bone marrow and blood smear examination in leukaemias)
2. Cytology
3. Surgery (including endoscopy), autopsy without histology, X-ray and some specified laboratory examinations
4. Clinical examination only
2 PUNLMP and ca in situ of the uroepithelium are included.